Pulse oximeter with alternate heart-rate determination

Information

  • Patent Grant
  • 8007441
  • Patent Number
    8,007,441
  • Date Filed
    Thursday, May 7, 2009
    15 years ago
  • Date Issued
    Tuesday, August 30, 2011
    13 years ago
Abstract
A pulse oximeter which determines multiple heart rates, and selects between them based on the metrics of only one of the heart rate calculations. A primary heart rate calculation method is selected, and is used unless its metrics indicate questionable accuracy, in which case an alternative rate calculation is available and is used instead.
Description
BACKGROUND OF THE INVENTION

The present invention relates to oximeters, and in particular to determining a pulse rate by multiple mechanisms in a detected waveform from a pulse oximeter.


Pulse oximetry is typically used to measure various blood chemistry characteristics including, but not limited to, the blood-oxygen saturation of hemoglobin in arterial blood, the volume of individual blood pulsations supplying the tissue, and the rate of blood pulsations corresponding to each heartbeat of a patient. Measurement of these characteristics has been accomplished by use of a non-invasive sensor which scatters light through a portion of the patient's tissue where blood perfuses the tissue, and photoelectrically senses the absorption of light in such tissue. The amount of light absorbed at various wavelengths is then used to calculate the amount of blood constituent being measured.


The light scattered through the tissue is selected to be of one or more wavelengths that are absorbed by the blood in an amount representative of the amount of the blood constituent present in the blood. The amount of transmitted light scattered through the tissue will vary in accordance with the changing amount of blood constituent in the tissue and the related light absorption. For measuring blood oxygen level, such sensors have typically been provided with a light source that is adapted to generate light of at least two different wavelengths, and with photodetectors sensitive to both of those wavelengths, in accordance with known techniques for measuring blood oxygen saturation.


Known non-invasive sensors include devices that are secured to a portion of the body, such as a finger; an ear or the scalp. In animals and humans, the tissue of these body portions is perfused with blood and the tissue surface is readily accessible to the sensor.


U.S. Pat. No. 6,083,172, No. 5,853,364 and No. 6,411,833 show multiple methods of calculating a pulse rate in a pulse oximeter; with a “best rate” module which arbitrates between the pulse rate calculations to select a best rate based on confidence levels associated with each. The confidence levels are calculated using various metrics to determine the reliability of the different pulse rate calculations. Also, U.S. Pat. No. 5,524,631 shows a fetal heart rate monitor that uses multiple parallel filter paths to identify the fetal heart rate, and uses a figure of merit operation to weight the different heart rate estimates.


N-100. The N-100 technology, dating to around 1985, accepted or rejected pulses based on pulse history of the size of pulses, pulse shape, expected time to occur (frequency) and ratio of R/IR.


In particular, the N-100 found pulses by looking for a signal maximum, followed by a point of maximum negative slope, then a minimum. The processing was done in a state machine referred to as “munch.” Each maximum was not qualified until the signal passed below a noise threshold, referred to as a noise gate. This acted as an adaptive filter since the noise gate level was set by feedback from a subsequent processing step to adapt to different expected signal amplitudes. The pulses are then accepted or rejected in a “Level3” process which was a filter which adapts to changing signals by comparing the amplitude, period and ratio-of-ratios (ratio of Red to IR, with Red and IR being expressed as a ratio of AC to DC) of a new pulse to the mean of values in a history buffer, then determining if the difference is within a confidence level. If the new pulse was accepted, the history buffer was updated with the values for the new pulse. The level3 process acted as an adaptive bandpass filter with center-frequency and bandwidth (confidence limits) being adapted by feedback from the output of the filter.


N-200. The N-200 improved on the N-100 since it could be synchronized with an ECG, and included ECG filtering. The N-200 also added interpolation to compensate for baseline shift between the time of measuring the pulse maximum and minimum. The N-200 included other filtering features as well, such as a “boxcar” filter which computed the mean of a varying number of signal samples.


The N-200, after various filtering and scaling steps, applies the digitized signals to a “boxcar” filter, which computes the mean of N samples, where N is set by feedback from a subsequent processing step according to the filtered heart rate. New samples are averaged into the boxcar filter, while the oldest samples are dropped. The boxcar length (N) is used to set three parameters: a pulse threshold, absolute minimum pulse and small pulse. An ensemble-averaging (a.k.a “slider”) filter then produces a weighted average of the new samples and the previous ensemble-averaged sample from one pulse-period earlier. The samples are then passed to a “munch” state machine and a noise gate, like the N-100. An interpolation feature is added to the N-100 process, to compensate for changes in the baseline level. Since the minimum and maximum occur at different times, a changing baseline may increase or decrease the minimum and not the maximum, or vice-versa.


“Ensemble averaging” is an integral part of C-Lock, which is NELLCOR's trademark for the process of averaging samples from multiple pulses together to form a composite pulse. This process is also known as “cardiac-gated averaging.” It requires a “trigger” event to mark the start of each pulse.


BRIEF SUMMARY OF THE INVENTION

The present invention is a pulse oximeter which determines multiple heart rates, and selects between them based on the metrics of only one of the heart rate calculations. A primary heart rate calculation method is selected, and is used unless its metrics indicate questionable accuracy, in which case an alternative rate calculation is available and is used instead.


In one embodiment, the primary heart rate calculation method does not use an ensemble averaged waveform, while the alternative heart rate calculation does use an ensemble averaged waveform. The alternative heart rate calculation is used if the primary calculation has disqualified its most recently detected pulse.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram of an oximetry system incorporating an embodiment of the invention.



FIG. 2 is a diagram of the software processing blocks of an oximeter including an embodiment of the present invention.



FIG. 3 is a context diagram of the pulse rate calculation subsystem.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 illustrates an embodiment of an oximetry system incorporating the present invention. A sensor 10 includes red and infrared LEDs and a photodetector. These are connected by a cable 12 to a board 14. LED drive current is provided by an LED drive interface 16. The received photocurrent from the sensor is provided to an I-V interface 18. The IR and red voltages are then provided to a sigma-delta interface 20 incorporating the present invention. The output of sigma-delta interface 20 is provided to a microcontroller 22 which includes a 10-bit A/D converter. Controller 22 includes flash memory for a program, and EEPROM memory for data. The processor also includes a controller chip 24 connected to a flash memory 26. Finally, a clock 28 is used and an interface 30 to a digital calibration in the sensor 10 is provided. A separate host 32 receives the processed information, as well as receiving an analog signal on a line 34 for providing an analog display.


Design Summary The design of the present invention is intended to deal with unwanted noise. Signal metrics are measured and used to determine filter weighting. Signal metrics are things that indicate if a pulse is likely a plethysmograph or noise, such as frequency (is it in the range of a human heart rate), shape (is it shaped like a heart pulse), rise time, etc. A similar technique was used in the Nellcor N200, described in the background of this application. The new design adds a number of different features and variations, such as the use of two ensemble averagers as claimed in the present invention.


Details of the architecture are shown in the diagram of FIG. 2. This design calculates both the oxygen saturation, and the pulse rate, which are described separately below.


I. Oxygen Saturation Calculation.


Signal Conditioning—The digitized red and IR signals are received and are conditioned in this block by (1) taking the 1st derivative to get rid of baseline shift, (2) low pass filtering with fixed coefficients, and (3) dividing by a DC value to preserve the ratio. The function of the Signal Conditioning subsystem is to emphasize the higher frequencies that occur in the human plethysmograph and to attenuate low frequencies in which motion artifact is usually concentrated. The Signal Conditioning subsystem selects its filter coefficients (wide or narrow band) based on hardware characteristics identified during initialization.

    • Inputs—digitized red and IR signals
    • Outputs—Pre-processed red and IR signals


Pulse Identification and Qualification—The low pass filtered and digitized red and IR signals are provided to this block to identify pulses, and qualify them as likely arterial pulses. This is done using a pre-trained neural net, and is primarily done on the JR signal. The pulse is identified by examining its amplitude, shape and frequency, just as was done in the Nellcor N-100. An input to this block is the average pulse period from block D. This function is similar to the N-100, which changed the upfront qualification using the pulse rate. The output indicates the degree of arrhythmia and individual pulse quality.

    • Inputs—(1) Pre-processed red and IR signals, (2) Ave. pulse period, (3) Lowpass Waveforms from the low pass filter.
    • Outputs—(1) Degree of arrhythmia, (2) pulse amplitude variations, (3) individual pulse quality, (4) Pulse beep notification, (5) qualified pulse periods and age.


C. Compute Signal Quality Metrics—This block determines the pulse shape (derivative skew), period variability, pulse amplitude and variability, Ratio of Ratios variability, and frequency content relative to pulse rate.

    • Inputs—(1) raw digitized red and IR signals, (2) degree of arrhythmia, individual pulse quality, pulse amplitude variation (3) pre-processed red and IR signals, (4) average pulse period.
    • Outputs—(1) Lowpass and ensemble averaging filter weights, (2) metrics for sensor off detector, (3) Normalized Pre-processed waveforms, (4) percent modulation.


Average Pulse Periods, This block calculates the average pulse period from the pulses received.

    • Inputs—Qualified pulse periods and age.
    • Outputs—Average pulse period.
    • E1. Lowpass Filter and Ensemble Averaging—Block E1 low pass filters and ensemble averages the signal conditioned by block A, and normalized by block C, for the pulse rate identification. The weights for the low pass filter are determined by the Signal Metrics block C. The signal is also ensemble averaged (this attenuates frequencies other than those of interest near the pulse rate and its harmonics), with the ensemble averaging filter weights also determined by Signal Metrics block C. Less weight is assigned if the signal is flagged as degraded. More weight is assigned if the signal is flagged as arrhythmic because ensemble-averaging is not appropriate during arrhythmia Red and R are processed separately, but with the same filtering weights. The filtering is delayed approximately one second to allow the signal metrics to be calculated first.


The filters use continuously variable weights. If samples are not to be ensemble-averaged, then the weighting for the previous filtered samples is set to zero in the weighted average, and the new samples are still processed through the code. This block tracks the age of the signal—the accumulated amount of filtering (sum of response times and delays in processing). Too old a result will be flagged (if good pulses haven't been detected for awhile).

    • Inputs—(1) normalized pre-processed red and IR signals, (2) average pulse period, (3) low pass filter weights and ensemble averaging filter weights, (4) ECG triggers, if available, (5) IR fundamental, for zero-crossing triggers.
    • Outputs—(1) filtered red and IR signals, (2) age.


Estimate Filtered Waveform Correlation and Calculate Averaging Weight—this uses a noise metric similar to that used in the N100 and N200 described above, and doesn't use feedback. The variable weighting for the filter is controlled by the ratio-of-ratios variance. The effect of this variable-weight filtering is that the ratio-of-ratios changes slowly as artifact increases and changes quickly as artifact decreases. The subsystem has two response modes. Filtering in the Fast Mode targets an age metric of 3 seconds. The target age is 5 seconds in Normal Mode. In Fast Mode, the minimum weighting of the current value is clipped at a higher level. In other words, a low weight is assigned to the newest ratio-of-ratios calculation if there is noise present, and a high weight if no noise is present.

    • Inputs—(1) filtered red and IR signals and age, (2) calibration coefficients, (3) response mode (user speed settings).
    • Outputs—averaging weight for ratio-of-ratios calculation.


Calculate Saturation—Saturation is calculated using an algorithm with the calibration coefficients and averaged ratio of ratios.

    • Inputs—(1) Averaged Ratio-of-Ratios, (2) calibration coefficients.
    • Outputs—Saturation.


      II. Pulse Rate Calculation.


E2. Lowpass Filter and Ensemble Averaging—Block E2 low pass filters and ensemble averages the signal conditioned by block A, for the pulse rate identification. The weights for the low pass filter are determined by the Signal Metrics block C. The signal is also ensemble averaged (this attenuates frequencies other than those of interest near the pulse rate and its harmonics), with the ensemble averaging filter weights also determined by Signal Metrics block C. Less weight is assigned if the signal is flagged as degraded. More weight is assigned if the signal is flagged as arrhythmic since filtering is not appropriate during arrhythmia. Red and IR are processed separately. The process of this block is delayed approximately one second to allow the signal metrics to be calculated first.


The filters use continuously variable weights. If samples are not to be ensemble-averaged, then the weighting for the previous filtered samples is set to zero in the weighted average, and the new samples are still processed through the code. This block tracks the age of the signal—the accumulated amount of filtering (sum of response times and delays in processing). Too old a result will be flagged (if good pulses haven't been detected for awhile).

    • Inputs—(1) pre-processed red and IR signals, (2) average pulse period, (3) Lowpass filter weights and ensemble averaging filter weights, (4) ECG triggers, if available, (5) IR fundamental, for zero-crossing triggers.
    • Outputs—(1) filtered red and IR signals, (2) age.


Filtered Pulse Identification and Qualification—This block identifies and qualifies pulse periods from the filtered waveforms, and its results are used only when a pulse is disqualified by block B.

    • Inputs—(1) filtered red and IR signals and age, (2) average pulse period, (3) hardware ID or noise floor, (4) kind of sensor,
    • Outputs—qualified pulse periods and age.


Average Pulse Periods and Calculate Pulse Rate—This block calculates the pulse rate and average pulse period.

    • Inputs—Qualified pulse periods and age
    • Outputs—(1) average pulse period, (2) pulse rate.


      Venous Pulsation


Detect Venous Pulsation—Block K receives as inputs the pre-processed red and IR signal and age from Block A, and pulse rate and provides an indication of venous pulsation as an output. This subsystem produces an IR fundamental waveform in the time domain using a single-tooth comb filter which is output to the Ensemble Averaging filters.

    • Inputs—(1) filtered red and IR signals and age, (2) pulse rate.
    • Outputs—Venous Pulsation Indication, IR fundamental


      IV. Sensor Off


Detect Sensor-Off and Loss of Pulse Amplitude—The Pulse Lost and Sensor Off Detection subsystem uses a pre-trained neural net to determine whether the sensor is off the patient. The inputs to the neural net are metrics that quantify several aspects of the behavior of the IR and Red values over the last several seconds. Samples are ignored by many of the oximetry algorithm's subsystems while the Signal State is not either Pulse Present or Sensor Maybe Off. The values of the Signal State variable are: “Pulse Present, Disconnect, Pulse Lost, Sensor Maybe Off, and Sensor Off.”

    • Inputs—(1) metrics, (2) front-end servo settings and ID
    • Outputs—Signal state including sensor-off indication


      Pulse Rate Calculation subsystem


The subsystem averages qualified pulse periods from the Pulse Identification and Qualification subsystem. It outputs the average period and the corresponding pulse rate.


The oximetry algorithm contains two instances of this subsystem. The first instance receives input from the Pulse Identification and Qualification instance whose input waveform have been processed by the Signal Conditioning subsystem, then lowpass filtered, but not ensemble averaged, by the Ensemble Averaging subsystem. The second instance of the Pulse Rate Calculation subsystem receives input from two instances of the Pulse Identification and Qualification subsystem, the one described above and a second instance that receives input that has been ensemble averaged.


Selection of Pulse Period Source


One instance of the subsystem receives qualified pulse periods from two sources. The subsystem selects which of these two sources to use for its pulse rate calculation based solely on analysis of only one source, the “primary” source. The oximetry algorithm designates the Pulse Identification and Qualification instance that does NOT receive ensemble-averaged waveforms as the primary source, and designates the other Pulse Identification and Qualification instance as the “alternate” source of qualified pulse periods. Qualified pulse periods from the alternate source are only used if the most recent pulse from the primary source was rejected. When a qualified pulse period is received from the primary source, it is always used to update the pulse-rate calculation, and will prevent qualified pulse periods from the alternate source from being used until the primary source once again rejects a pulse period,


Calculation of Average Pulse Period and Pulse-Rate Estimate


When the subsystem uses a Qualified_Pulse_Period, it updates its average pulse period, Avg_Period, using a pulse-based, variable-weight IIR filter, then computes its Rate output from Avg_Period. The steps for this filtering operation are:

  • 1. rt=(60/Δt)/Qualified_Pulse_Period
  • 2. k=Consecutive_Qualified/max(|rt−rt-1|, |rt-1−rt-2|, |rt-2−rt-3|, 1.0)
  • 3. x=bound(min(Avg_Periodt-1, Qualified_Pulse_Period, ¾ seconds, 2 seconds)/7 seconds
  • 4. If Rate_Age>10 seconds, x=min(x*Rate_Age/10 seconds, 0.3)
  • 5. k=max(1/Total_Qualified, min(k, x))
  • 6. If Avg_Periodt-1 custom character Avg_Periodt=Avg_Periodt-1*(Qualified_Pulse_Period/Avg_Periodt-1)k
  • 7. If Avg_Periodt-1=0 Avg_Periodt=Qualified_Pulse_Period
  • 8. Rate=(60/Δt)/Avg_Periodt
  • 9. Rate_Age=Rate_Age+k*(Qualified_Period_Age−Rate_Age)


    where:


    rt is the pulse rate corresponding to Qualified_Pulse_Period, in BPM


    thet-1 subscript denotes the previous qualified pulse.


    Δt is the oximetry algorithm's sample interval in seconds


    60/Δt is the number of samples per minute


    x is a filter weight that targets a 7-second response time for typical adult pulse rates.


    k is the final filter weight, based on both x and the differences between consecutive values of rt. During the first few pulses, k is increased to at least 1/Total_Qualified so that the initial qualified pulses will be weighted equally.


Consecutive_Qualified is the number of consecutive qualified pulses, and Total_Qualified is the total number of pulses qualified since the subsystem was reinitialized. Both Consecutive_Qualified and Total_Qualified are incremented each time a Qualified_Pulse_Period is used, before k is calculated. Consecutive_Qualified is set to zero when a pulse is rejected by the pulse-period source currently in use.


The update formula for Avg_Periodt, in step 6 above, is a geometric average of Avg_Periodt and Qualified_Pulse_Period. Geometric averaging helps to keep the subsystem responsive to large pulses-to-pulse period variations, and large, sustained changes in pulse rate.


Once Rate is initialized to a non-zero value, Rate_Age is incremented every sample, whether or not Rate is updated.


Context Diagram



FIG. 3 is a context diagram of the pulse rate calculation subsystem. The subsystem updates its Avg_Period and Rate outputs from Qualified_Pulse_Periods. It uses Qualified_Pulse_Periods from the Alternative_Period_Source only if it last received a Notify_Pulse_Rejected from the primary source. It updates its Rate_Age output based on Qualified_Period_Age. When Rate is updated, the subsystem sets its Pulse_Rate_Updated flag. The Reinitialize input tells the subsystem to reinitialize itself. Increment_Rate_Age notifies the subsystem to increment its Rate_Age every sample once Rate is initialized.

Claims
  • 1. A method for determining a heart rate in a pulse oximeter comprising: using a processor to determine a first heart rate from a pulse oximetry signal using a first method;using the processor to determine a second heart rate from the pulse oximetry signal using a second method;using the processor to evaluate a reliability of the first heart rate using metrics applied to the pulse oximetry signal;using the processor to select the first heart rate when the metrics indicate the first method is reliable;using the processor to select the second heart rate only when the metrics indicate that the first heart rate is unreliable; andusing the processor to provide an indication on a display of the first heart rate or the second heart rate.
  • 2. The method of claim 1, comprising using the processor to determine that the first heart rate is unreliable when the metrics indicate that a most recent pulse is rejected.
  • 3. The method of claim 1, wherein the first method does not use an ensemble averaged waveform, and the second method does use an ensemble averaged waveform.
  • 4. The method of claim 1, comprising filtering the pulse oximetry signal with a low pass filter.
  • 5. The method of claim 4, wherein filter weights for the low pass filter are determined using the metrics applied to the pulse oximetry signal.
  • 6. The method of claim 5, wherein the metrics comprise one or more of pulse shape, period variability, pulse amplitude and variability, ratio of ratios variability, or frequency content relative to pulse rate.
  • 7. The method of claim 1, wherein using the processor to determine a first or second heart rate comprises determining a pulse period.
  • 8. A pulse oximetry system, comprising: a sensor adapted to provide a signal related to a physiological constituent; anda monitor adapted to process the signal to determine a pulse period, the monitor comprising: software configured to identify one or more qualified pulses from the signal, wherein the one or more qualified pulses comprise likely arterial pulses;software configured to determine a first pulse period from the one or more qualified pulses using a first method;software adapted to determine a second pulse period from the one or more qualified pulses using a second method;an evaluator configured to determine the reliability of the first pulse period using metrics applied to the pulse oximetry signal; anda selector configured to use the first pulse period when the metrics indicate the first pulse period is reliable, and to use the second pulse period only when the metrics indicate that the first pulse period is unreliable.
  • 9. The system of claim 8, wherein the first method does not use an ensemble averaged waveform, and the second method does use an ensemble averaged waveform.
  • 10. The system of claim 8, wherein the first pulse period or the second pulse period is converted into a heart rate.
  • 11. The system of claim 8, wherein the first pulse period is unreliable when the metrics indicate that a most recent pulse is rejected.
  • 12. The system of claim 8, comprising software configured to update the pulse period using a pulse-based variable-weight filter.
  • 13. The system of claim 8, wherein the system is configured to filter the signal with a low pass filter.
  • 14. The system of claim 13, wherein filter weights for the low pass filter are determined using the metrics applied to the signal.
  • 15. The system of claim 14 wherein the metrics comprise one or more of pulse shape, period variability, pulse amplitude and variability, ratio of ratios variability, or frequency content relative to pulse rate.
  • 16. The system of claim 8, wherein the software configured to identify one or more qualified pulses from the signal comprises a neural net.
  • 17. The system of claim 8, wherein the software configured to identify one or more qualified pulses from the signal comprises a state machine.
  • 18. A method for determining a heart rate in a pulse oximeter comprising: using a processor to determine a first pulse period from a pulse oximetry signal using a first method;using the processor to evaluate a reliability of the first pulse period using metrics applied to the pulse oximetry signal;using the processor to determine a second pulse period from the pulse oximetry signal using a second method only when the metrics indicate that the first pulse period is unreliable;using the processor to convert the first pulse period into a heart rate when the metrics indicate that the first pulse period is reliable;using the processor to convert the second pulse period into a heart rate only when the metrics indicate that the first pulse period is unreliable; andusing the processor to provide an indication on a display of the heart rate.
  • 19. The method of claim 18, wherein the first method does not use an ensemble averaged waveform, and wherein the second method does use an ensemble averaged waveform.
CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 10/796,566, filed Mar. 8, 2004, the disclosure of which is hereby incorporated by reference in its entirety for all purposes.

US Referenced Citations (263)
Number Name Date Kind
3638640 Shaw Feb 1972 A
4714341 Hamaguri et al. Dec 1987 A
4805623 Jöbsis Feb 1989 A
4807631 Hersh et al. Feb 1989 A
4911167 Corenman et al. Mar 1990 A
4913150 Cheung et al. Apr 1990 A
4936679 Mersch Jun 1990 A
4938218 Goodman et al. Jul 1990 A
4971062 Hasebe et al. Nov 1990 A
4972331 Chance Nov 1990 A
4974591 Awazu et al. Dec 1990 A
5028787 Rosenthal et al. Jul 1991 A
5065749 Hasebe et al. Nov 1991 A
5084327 Stengel Jan 1992 A
5119815 Chance Jun 1992 A
5122974 Chance Jun 1992 A
5167230 Chance Dec 1992 A
5190038 Polson et al. Mar 1993 A
5246003 DeLonzor Sep 1993 A
5247931 Norwood Sep 1993 A
5263244 Centa et al. Nov 1993 A
5275159 Griebel Jan 1994 A
5279295 Martens et al. Jan 1994 A
5297548 Pologe Mar 1994 A
5355880 Thomas et al. Oct 1994 A
5365934 Leon et al. Nov 1994 A
5372136 Steuer et al. Dec 1994 A
5385143 Aoyagi Jan 1995 A
5390670 Centa et al. Feb 1995 A
5413099 Schmidt et al. May 1995 A
5469845 DeLonzor et al. Nov 1995 A
5482036 Diab et al. Jan 1996 A
5483646 Uchikoga Jan 1996 A
5485847 Baker et al. Jan 1996 A
5524631 Zahorian et al. Jun 1996 A
5553614 Chance Sep 1996 A
5558086 Smith et al. Sep 1996 A
5564417 Chance Oct 1996 A
5575285 Takanashi et al. Nov 1996 A
5611337 Bukta Mar 1997 A
5630413 Thomas et al. May 1997 A
5645059 Fein et al. Jul 1997 A
5645060 Yorkey Jul 1997 A
5680857 Pelikan et al. Oct 1997 A
5692503 Kuenstner Dec 1997 A
5730124 Yamauchi Mar 1998 A
5758644 Diab et al. Jun 1998 A
5759157 Harada et al. Jun 1998 A
5779631 Chance Jul 1998 A
5782757 Diab et al. Jul 1998 A
5786592 Hök Jul 1998 A
5797840 Akselrod et al. Aug 1998 A
5830136 Delonzor et al. Nov 1998 A
5830139 Abreu Nov 1998 A
5831598 Kauffert et al. Nov 1998 A
5842981 Larsen et al. Dec 1998 A
5871442 Madarasz et al. Feb 1999 A
5873821 Chance et al. Feb 1999 A
5920263 Huttenhoff et al. Jul 1999 A
5995855 Kiani et al. Nov 1999 A
5995856 Mannheimer et al. Nov 1999 A
5995859 Takahashi Nov 1999 A
6011986 Diab et al. Jan 2000 A
6035223 Baker, Jr. Mar 2000 A
6064898 Aldrich May 2000 A
6081742 Amano et al. Jun 2000 A
6083172 Baker, Jr. et al. Jul 2000 A
6088607 Diab et al. Jul 2000 A
6120460 Abreu Sep 2000 A
6134460 Chance Oct 2000 A
6150951 Olejniczak Nov 2000 A
6154667 Miura et al. Nov 2000 A
6157850 Diab et al. Dec 2000 A
6163715 Larsen et al. Dec 2000 A
6178343 Bindszus et al. Jan 2001 B1
6181958 Steuer et al. Jan 2001 B1
6181959 Schollermann et al. Jan 2001 B1
6230035 Aoyagi et al. May 2001 B1
6266546 Steuer et al. Jul 2001 B1
6285895 Ristolainen et al. Sep 2001 B1
6312393 Abreu Nov 2001 B1
6353750 Kimura et al. Mar 2002 B1
6374129 Chin et al. Apr 2002 B1
6397091 Diab et al. May 2002 B2
6408198 Hanna et al. Jun 2002 B1
6411833 Baker et al. Jun 2002 B1
6415236 Kobayashi et al. Jul 2002 B2
6419671 Lemberg Jul 2002 B1
6438399 Kurth Aug 2002 B1
6449501 Reuss Sep 2002 B1
6461305 Schnall Oct 2002 B1
6466809 Riley Oct 2002 B1
6487439 Skladnev et al. Nov 2002 B1
6501974 Huiku Dec 2002 B2
6501975 Diab et al. Dec 2002 B2
6526301 Larsen et al. Feb 2003 B2
6544193 Abreu Apr 2003 B2
6546267 Sugiura et al. Apr 2003 B1
6549795 Chance Apr 2003 B1
6580086 Schulz et al. Jun 2003 B1
6584336 Ali et al. Jun 2003 B1
6591122 Schmitt Jul 2003 B2
6594513 Jobsis et al. Jul 2003 B1
6606509 Schmitt Aug 2003 B2
6606511 Ali et al. Aug 2003 B1
6615064 Aldrich Sep 2003 B1
6618042 Powell Sep 2003 B1
6622095 Kobayashi et al. Sep 2003 B2
6654621 Palatnik et al. Nov 2003 B2
6654624 Diab et al. Nov 2003 B2
6658276 Pishney et al. Dec 2003 B2
6658277 Wasserman Dec 2003 B2
6662030 Khalil et al. Dec 2003 B2
6668183 Hicks et al. Dec 2003 B2
6671526 Aoyagi et al. Dec 2003 B1
6671528 Steuer et al. Dec 2003 B2
6678543 Diab et al. Jan 2004 B2
6684090 Ali et al. Jan 2004 B2
6690958 Walker et al. Feb 2004 B1
6697658 Al-Ali Feb 2004 B2
6708048 Chance Mar 2004 B1
6711424 Fine et al. Mar 2004 B1
6711425 Reuss Mar 2004 B1
6714245 Ono Mar 2004 B1
6731274 Powell May 2004 B2
6785568 Chance Aug 2004 B2
6793654 Lemberg Sep 2004 B2
6801797 Mannheimer et al. Oct 2004 B2
6801798 Geddes et al. Oct 2004 B2
6801799 Mendelson Oct 2004 B2
6829496 Nagai et al. Dec 2004 B2
6836679 Baker, Jr. et al. Dec 2004 B2
6850053 Daalmans et al. Feb 2005 B2
6852083 Caro et al. Feb 2005 B2
6862091 Johnson Mar 2005 B2
6863652 Huang et al. Mar 2005 B2
6873865 Steuer et al. Mar 2005 B2
6889153 Dietiker May 2005 B2
6898451 Wuori May 2005 B2
6939307 Dunlop Sep 2005 B1
6944488 Roberts et al. Sep 2005 B2
6947780 Scharf Sep 2005 B2
6949081 Chance Sep 2005 B1
6961598 Diab Nov 2005 B2
6983178 Fine et al. Jan 2006 B2
6993371 Kiani et al. Jan 2006 B2
6996427 Ali et al. Feb 2006 B2
7006856 Baker, Jr. et al. Feb 2006 B2
7016715 Stetson Mar 2006 B2
7024235 Melker et al. Apr 2006 B2
7025730 Cho et al. Apr 2006 B2
7027849 Al-Ali Apr 2006 B2
7030749 Al-Ali Apr 2006 B2
7035697 Brown Apr 2006 B1
7047056 Hannula et al. May 2006 B2
7083593 Stultz Aug 2006 B2
7085597 Fein et al. Aug 2006 B2
7127278 Melker et al. Oct 2006 B2
7130671 Baker, Jr. et al. Oct 2006 B2
7162306 Caby et al. Jan 2007 B2
7209775 Bae et al. Apr 2007 B2
7236811 Schmitt Jun 2007 B2
7263395 Chan et al. Aug 2007 B2
7272426 Schmid Sep 2007 B2
7302284 Baker, Jr. et al. Nov 2007 B2
7315753 Baker, Jr. et al. Jan 2008 B2
7336983 Baker, Jr. et al. Feb 2008 B2
7373193 Al-Ali et al. May 2008 B2
7379769 Piron et al. May 2008 B2
7398115 Lynn Jul 2008 B2
7400918 Parker et al. Jul 2008 B2
7455643 Li et al. Nov 2008 B1
7499740 Nordstrom et al. Mar 2009 B2
7534212 Baker, Jr. May 2009 B2
20010005773 Larsen et al. Jun 2001 A1
20010020122 Steuer et al. Sep 2001 A1
20010039376 Steuer et al. Nov 2001 A1
20010044700 Kobayashi et al. Nov 2001 A1
20020026106 Khalil et al. Feb 2002 A1
20020035318 Mannheimer et al. Mar 2002 A1
20020038079 Steuer et al. Mar 2002 A1
20020042558 Mendelson Apr 2002 A1
20020049389 Abreu Apr 2002 A1
20020062071 Diab et al. May 2002 A1
20020072660 Diab et al. Jun 2002 A1
20020111748 Kobayashi et al. Aug 2002 A1
20020128544 Diab et al. Sep 2002 A1
20020133068 Huiku Sep 2002 A1
20020137994 Baker et al. Sep 2002 A1
20020156354 Larson Oct 2002 A1
20020161287 Schmitt Oct 2002 A1
20020161290 Chance Oct 2002 A1
20020165439 Schmitt Nov 2002 A1
20020198443 Ting Dec 2002 A1
20030023140 Chance Jan 2003 A1
20030055324 Wasserman Mar 2003 A1
20030060693 Monfre et al. Mar 2003 A1
20030109798 Kermani Jun 2003 A1
20030139687 Abreu Jul 2003 A1
20030144584 Mendelson Jul 2003 A1
20030163057 Flick et al. Aug 2003 A1
20030220548 Schmitt Nov 2003 A1
20030220576 Diab Nov 2003 A1
20040010188 Wasserman Jan 2004 A1
20040015091 Greenwald et al. Jan 2004 A1
20040054270 Pewzner et al. Mar 2004 A1
20040087846 Wasserman May 2004 A1
20040107065 Al-Ali Jun 2004 A1
20040127779 Steuer et al. Jul 2004 A1
20040138540 Baker et al. Jul 2004 A1
20040158135 Baker, Jr. et al. Aug 2004 A1
20040171920 Mannheimer et al. Sep 2004 A1
20040176670 Takamura et al. Sep 2004 A1
20040176671 Fine et al. Sep 2004 A1
20040181134 Baker et al. Sep 2004 A1
20040230106 Schmitt et al. Nov 2004 A1
20050043599 O'Mara Feb 2005 A1
20050080323 Kato Apr 2005 A1
20050085735 Baker, Jr. et al. Apr 2005 A1
20050101850 Parker May 2005 A1
20050113651 Wood et al. May 2005 A1
20050113656 Chance May 2005 A1
20050119543 Parker et al. Jun 2005 A1
20050119586 Coyle et al. Jun 2005 A1
20050143634 Baker, Jr. Jun 2005 A1
20050154370 Sigg et al. Jul 2005 A1
20050168722 Forstner et al. Aug 2005 A1
20050177034 Beaumont Aug 2005 A1
20050188991 Sun et al. Sep 2005 A1
20050192488 Bryenton et al. Sep 2005 A1
20050192500 Caro et al. Sep 2005 A1
20050203357 Debreczeny et al. Sep 2005 A1
20050228248 Dietiker Oct 2005 A1
20050267346 Faber et al. Dec 2005 A1
20050283059 Iyer et al. Dec 2005 A1
20060009688 Lamego et al. Jan 2006 A1
20060015021 Cheng Jan 2006 A1
20060020181 Schmitt Jan 2006 A1
20060030763 Mannheimer et al. Feb 2006 A1
20060030766 Stetson Feb 2006 A1
20060052680 Diab Mar 2006 A1
20060058683 Chance Mar 2006 A1
20060064024 Schnall Mar 2006 A1
20060122475 Balberg et al. Jun 2006 A1
20060135860 Baker, Jr. et al. Jun 2006 A1
20060195028 Hannula et al. Aug 2006 A1
20060217604 Fein et al. Sep 2006 A1
20060217605 Fein et al. Sep 2006 A1
20060217606 Fein et al. Sep 2006 A1
20060217607 Fein et al. Sep 2006 A1
20060217608 Fein et al. Sep 2006 A1
20060217774 Mower et al. Sep 2006 A1
20060224058 Mannheimer Oct 2006 A1
20060229510 Fein et al. Oct 2006 A1
20060229511 Fein et al. Oct 2006 A1
20060241975 Brown Oct 2006 A1
20060247501 Ali Nov 2006 A1
20060247506 Balberg et al. Nov 2006 A1
20060258921 Addison et al. Nov 2006 A1
20060285736 Brown Dec 2006 A1
20080059249 Joao Mar 2008 A1
20080059250 Joao Mar 2008 A1
20080132771 Parker et al. Jun 2008 A1
Foreign Referenced Citations (22)
Number Date Country
1006863 Oct 2003 EP
1006864 Oct 2003 EP
1491135 Dec 2004 EP
3170866 Jul 1991 JP
7124138 May 1995 JP
7136150 May 1995 JP
2003194714 Jul 2003 JP
2003210438 Jul 2003 JP
2004008572 Jan 2004 JP
2004113353 Apr 2004 JP
2004194908 Jul 2004 JP
2004248819 Sep 2004 JP
2004290545 Oct 2004 JP
WO 9101678 Feb 1991 WO
WO 9309711 May 1993 WO
WO 9608992 Mar 1996 WO
WO 9843071 Oct 1998 WO
WO 9932030 Jul 1999 WO
WO 0021438 Apr 2000 WO
WO 03084396 Oct 2003 WO
WO 2004075746 Sep 2004 WO
WO 2005025399 Mar 2005 WO
Related Publications (1)
Number Date Country
20090221889 A1 Sep 2009 US
Continuations (1)
Number Date Country
Parent 10796566 Mar 2004 US
Child 12437335 US